| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.0028 | 1 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |